University of Dundee

The 2012 Bridget Ogilvie Lecture - Dr Craig Thompson, Friday 1st June 2012 at 4 pm, Large Lecture Theatre MSI

17 May 2012

The Bridget Ogilvie Lecture, given by Dr Craig Thompson

"Fuelling cell growth: new insights from cancer metabolism"

Friday 1st June 2012

4pm, Large Lecture Theatre, MSI

ALL WELCOME

About the speaker

Dr Craig Thompson is President and Chief Executive Office of Memorial Sloan-Kettering Cancer Center, New York, USA.

Dr. Thompson's current research focuses on the role that metabolic changes play in the origin and progression of cancer. He has also done pioneering research on the genes that control programmed cell death and how the misregulation of such genes can contribute to cancer. In earlier work he contributed to the development of innovative treatments for autoimmune diseases and leukaemia.
Dr. Thompson is a board-certified internist and medical oncologist, and has extensive research experience in cancer, immunology, and translational medicine. In 2003, he was elected to the Institute of Medicine and in 2005 was elected to the National Academy of Sciences. He currently serves as chair of the HHMI Medical Advisory Board. He is also a member of the Board of Directors of the Association of American Cancer Institutes and the American Association for Cancer Research, and is a member of the Lasker Prize Jury. Dr. Thompson has been a member of the advisory boards of several cancer centers including St. Jude Children's Research Hospital and the University of Texas MD Anderson Cancer Center.

About the lecture series

The Bridget Ogilvie Lecture is named after Dame Bridget Ogilvie who was Director of the Wellcome Trust 1991 - 1998 and who played an important role in the development of the College of Life Sciences, in particular in the special award of £10 million that lead to the building of the Wellcome Trust Building in 1997.  Each Division in WTB takes turns in nominating the Bridget Ogilvie Lecturer and this
year is the turn of CSI.

Share